Infographic: Cancer Drug Pairings
Anna Azvolinsky | Mar 31, 2018
Researchers use several different strategies to deliver a one-two punch.
Sanofi and Celgene Spend $20 Billion in Major Biotech Acquisitions
Katarina Zimmer | Jan 23, 2018
Pharmaceutical giant Sanofi to take over hemophilia drugmaker Biovertiv, while Celgene will buy cancer drugmaker Juno Therapeutics.
AbbVie Wins Bidding War for Cancer Drugmaker
Bob Grant | Mar 5, 2015
The pharmaceutical firm beat out a host of potential suitors, Johnson & Johnson among them, to strike a $21 billion deal with Pharmacyclics.
Lavish Spending at MD Anderson
Kate Yandell | May 28, 2013
The public cancer center is criticized for allegedly devoting at least $1.5 million to remodeling an executive suite.
Spinning Clinical Trials
Dan Cossins | Jan 16, 2013
Results of breast cancer drug trials are regularly spun to conceal bias and make the drugs seem more effective or less toxic than they really are.
$18M Grant to Be Re-reviewed
Jef Akst | Jun 1, 2012
A Texas cancer institute is taking a second look at the largest grant it ever awarded after concerns were raised that the proposal never received proper scientific review.
Collecting Cancer Data
Hannah Waters | Mar 29, 2012
Two new cancer cell line databases bursting with genomic and drug profiling data may help researchers identify drug targets.